Servatus was established in 2012 and began operations in 2013. It is an unlisted public company with headquarters the University of Sunshine Coast’s Innovation Centre.
Servatus and an international joint-venture partner are building a state-of-the-art production and research facility at Coolum in Queensland to produce medical-grade biopharmaceuticals. The first stage of the facility is expected to be completed by the end of the fourth quarter in 2019.
The company derives its name from St Servatus who was a churchman and diplomat in the fourth century and became Bishop of Tongeren, a city and municipality now in modern-day Belgium. Servatius was invoked by Catholics as a patron saint, with healing powers for a range of ailments, including rheumatism